| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| car-t cells targeting muc1 | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1/2 | unknown |
| car-t cells targeting muc1 | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Lymphocyte[MeSHID:D013601] cervical cancer[MeSHID:D002583] |
NA | phase 1 | unknown |
| car-t cells targeting muc1 | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Lymphocyte[MeSHID:D013601] cervical cancer[MeSHID:D002583] |
NA | phase 1/2 | unknown |
| car-t cells targeting muc1 | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||